Hoffmann La Roche competitive analysis

Latest publications and patents of Hoffmann La Roche New

Explore the latest publications and patents granted to Hoffmann La Roche, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Hoffmann La Roche

Feb 12, 2020Body-Wearable Medical Device -

Explore patent oppositions filed by Hoffmann La Roche against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDHOFERNov 15, 2021
Prevention Of Adverse Effects Caused By Cd3 Specific Binding DomainsAMGEN RESEARCH MUNICHAug 24, 2021
Modulation Of Ube3A-Ats ExpressionBAYLOR COLLEGE OF MEDICINEMar 26, 2021
Antibodies And Fragments Thereof Raised Against The Alpha-3 Domain Of Hla-G Protein, Methods And Means For Their Preparation, And Uses ThereofINVECTYSOct 8, 2020
Compositions And Methods For Modulating Immune ResponsesZYMOGENETICSSep 11, 2020
Compositions And Methods Of Treating TumorsTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIADec 13, 2019
Modulation Of Ube3A-Ats ExpressionBAYLOR COLLEGE OF MEDICINEMay 14, 2019
Immunotherapeutic Molecules And UsesTHE UNIVERSITY OF BIRMINGHAMApr 23, 2019
Methods Of Preventing And Removing Trisulfide BondsBIOGEN IDEC MAJan 4, 2019
Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In BioreactorsWYETHSep 19, 2018

Latest PTAB cases involving Hoffmann La Roche

Discover the latest PTAB cases involving Hoffmann La Roche, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 29, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Hoffmann La Roche

IPR2017-02066Sep 7, 2017COHERUS BIOSCIENCESHOFFMANN LA ROCHEInstitution Denied
IPR2017-01916Aug 4, 2017COHERUS BIOSCIENCESHOFFMANN LA ROCHEInstitution Denied
IPR2015-01792Aug 22, 2015COALITION FOR AFFORDABLE DRUGS VHOFFMANN LA ROCHEInstitution Denied

Peer Comparison New

IP litigation analysis comparing Hoffmann La Roche with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
F HOFFMANN LA ROCHE16130 - - Defensive
BAYER3156 - - Balanced
HOFFMANN EITLE147 - - - Highly Aggressive
STRAWMAN329 - - - Highly Aggressive